The Inventing Press

HCA Healthcare, Inc.

Financial highlights

MetricFY 12/31/25FY 12/31/24FY 12/31/23FY 12/31/22FY 12/31/21
Income Statement
Revenue$75.6B$70.6B$65.0B$60.2B$58.8B
Interest expense$2.2B$2.1B$1.9B$1.7B$1.6B
Pretax income$9.8B$8.5B$7.7B$8.6B$9.8B
Income tax expense$2.0B$1.9B$1.6B$1.7B$2.1B
Net income$6.8B$5.8B$5.2B$5.6B$7.0B
Balance Sheet
Cash and equivalents$1.0B$1.9B$935.0M$908.0M$1.5B
Current assets$15.8B$16.4B$14.9B$13.6B$13.5B
Total assets$60.7B$59.5B$56.2B$52.4B$50.7B
Current liabilities$16.4B$15.2B$12.7B$9.9B$9.6B
Total debt$46.5B$43.0B$39.9B$38.4B$34.8B
Stockholders' equity-$6.0B-$2.5B-$1.8B-$2.8B-$933.0M
Cash Flow Statement
Cash from operations$12.6B$10.5B$9.4B$8.5B$9.0B
Depreciation and amortization$3.5B$3.3B$3.1B$3.0B$2.9B
Stock-based compensation$401.0M$360.0M$262.0M$341.0M$440.0M
Capital expenditure$4.9B$4.9B$4.7B$4.4B$3.6B
Free cash flow$7.7B$5.6B$4.7B$4.1B$5.4B
Dividends paid$679.0M$690.0M$661.0M$653.0M$624.0M
Share repurchases$10.1B$6.0B$3.8B$7.0B$8.2B
Impairments$0$0$0$0$0

Shares outstanding 221.8M

Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.

Recent filings

  • July 14, 2026 8-K
  • June 18, 2026 8-K
  • April 30, 2026 8-K
  • April 29, 2026 10-Q
  • April 28, 2026 8-K
  • April 27, 2026 8-K
  • April 24, 2026 8-K
  • February 25, 2026 8-K

Earnings